Johnson & Johnson Reports Q2 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
'Sunshine and Blue Skies' Ahead For Johnson & Johnson (JNJ) Following Strong Q2 Beat
July 21, 2021 9:53 AM EDTEarlier today, Johnson & Johnson (NYSE: JNJ) reported a strong Q2 beat both on the top and bottom lines: EPS of $2.48, $0.22 better than the analyst estimates of $2.26, and revenues of $23.31B versus the consensus estimate of $22.19B.
The company also revised its full-year guidance to the upside: FY2021 EPS of $9.60-$9.70, vs consensus of... More
Johnson & Johnson (JNJ) Tops Q2 EPS by 22c, Updates FY Guidance
July 21, 2021 6:28 AM EDTJohnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.48, $0.22 better than the analyst estimate of $2.26. Revenue for the quarter came in at $23.31 billion versus the consensus estimate of $22.19 billion.
GUIDANCE:
Johnson & Johnson sees FY2021 EPS of $9.60-$9.70, versus the consensus of $9.52.... More
